PTP
ABEO icon

Platform Technology Partners’s Abeona Therapeutics ABEO Stock Holding History

Platform Technology Partners’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-740
Closed -$21K – 229
2021
Q3 		$21K Hold
740
– – 0.01% 233
2021
Q2 		$29K Buy
+740
New +$30.2K 0.01% 257
2020
Q4 		$43K Buy
1,108
+288
+35% +$9.81K 0.02% 230
2020
Q3 		$21K Hold
820
– – 0.01% 202
2020
Q2 		$60K Hold
820
– – 0.04% 191
2020
Q1 		$43K Buy
820
+340
+71% +$22.7K 0.04% 167
2019
Q4 		$39K Buy
+480
New +$33.9K 0.03% 178

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Platform Technology Partners's ABEO Position: Q4 2021 in Review

Platform Technology Partners sold out of Abeona Therapeutics (ABEO) in Q4 2021, closing a stake of 740 shares — an estimated $21K sold.

Platform Technology Partners first reported a position in ABEO in Q4 2019 and held it in 7 quarters. The position peaked at $60K in Q2 2020. 52 funds tracked by Wall St. Rank hold ABEO as of Q4 2021.

  • Platform Technology Partners reported no remaining Abeona Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Platform Technology Partners sold 740 Abeona Therapeutics shares in Q4 2021, an estimated $21K.
  • Platform Technology Partners first reported a position in Abeona Therapeutics in Q4 2019 and held it in 7 quarters.
  • Platform Technology Partners's Abeona Therapeutics position peaked at $60K in Q2 2020.
  • 52 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2021.

Based on Platform Technology Partners's 13F filing for Q4 2021, filed 1 Feb 2022.